Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex Source: Eur Respir J 2003; 21: 241-247 Year: 2003
Relationship between obstructive sleep apnea syndrome (OSAS) and obesity, cholesterol disorders, blood pressure, and anatomical alterations Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006
Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP Source: Eur Respir J 2007; 30: 496-500 Year: 2007
Early changes in blood pressure, vascular and heart function in obstructive sleep apnoea (OSA). Impact of treatment Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Exploring the impact of continuous positive airway pressure treatment on biological clock disruption in obstructive sleep apnea patients Source: Sleep and Breathing Conference 2021 Year: 2021
Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea: Effect of continuous positive airway pressure treatment Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Exacerbation of sleep-apnoea related nocturnal blood-pressure fluctuations in hypertensive subjects Source: Eur Respir J 2002; 20: 151-157 Year: 2002
CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea Source: Eur Respir J 2008; 32: 1009-1015 Year: 2008
Effects of continuous positive airway pressure therapy in patients with severe obstructive sleep apnea and endothelial dysfunction on 24-hour blood pressure profile Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Peculiarities of GABA levels in plasma and urine of asthma patients with obstructive sleep apnea Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea Year: 2020
Impact of obstructive sleep apnoea and intermittent hypoxia on blood rheology: a translational study Source: Eur Respir J, 58 (4) 2100352; 10.1183/13993003.00352-2021 Year: 2021
The effect of fluid overload on sleep apnoea severity in haemodialysis patients Source: Eur Respir J , 49 (4) 1601789; DOI: 10.1183/13993003.01789-2016 Year: 2017
Differential blood pressure response to continuous positive airway pressure treatment according to the circadian pattern in hypertensive patients with obstructive sleep apnoea Source: Eur Respir J, 54 (1) 1900098; 10.1183/13993003.00098-2019 Year: 2019
Effects of treatments with nCPAP on cerebral blood flow velocity in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009
Blood pressure responsiveness to obstructive events during sleep after chronic CPAP Source: Eur Respir J 2003; 21: 509-514 Year: 2003
14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans Source: Eur Respir J 2011; 37: 119-128 Year: 2011
Cardiac performance indices and neurohumoral activation in patients with stable chronic heart failure and sleep disordered breathing Source: Annual Congress 2009 - Pathogenesis of sleep-disordered breathing Year: 2009
Circadian rhythm of systemic blood pressure in men with obstructive sleep apnoea syndrome ( OSAS ) Source: Eur Respir J 2001; 18: Suppl. 33, 89s Year: 2001
Role of positive airway pressure (CPAP/BOPAP) in patients with combined heart failure and sleep apnoea Source: International Congress 2019 – Breathing disorders, cardiovascular disease and pulmonary embolism guidelines Year: 2019
Bicarbonate venous blood level in obstructive sleep apnea syndrome: Any correlation with nocturnal hypoxia? Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea Year: 2021